

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | definitive hemopoiesis (GO:0060216) | 7.99839389 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 7.85128646 |
| 3 | thrombin receptor signaling pathway (GO:0070493) | 7.39743813 |
| 4 | platelet dense granule organization (GO:0060155) | 6.69603590 |
| 5 | aggressive behavior (GO:0002118) | 6.67020024 |
| 6 | endothelium development (GO:0003158) | 5.78015155 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.77347165 |
| 8 | viral transcription (GO:0019083) | 5.75408318 |
| 9 | negative regulation of erythrocyte differentiation (GO:0045647) | 5.58838143 |
| 10 | regulation of female receptivity (GO:0045924) | 5.57235169 |
| 11 | translational termination (GO:0006415) | 5.55362943 |
| 12 | megakaryocyte development (GO:0035855) | 5.41630239 |
| 13 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.25149671 |
| 14 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 5.23998415 |
| 15 | response to interferon-beta (GO:0035456) | 5.06632215 |
| 16 | female mating behavior (GO:0060180) | 4.97086670 |
| 17 | endosome to melanosome transport (GO:0035646) | 4.92519088 |
| 18 | endosome to pigment granule transport (GO:0043485) | 4.92519088 |
| 19 | angiogenesis involved in wound healing (GO:0060055) | 4.90239921 |
| 20 | mature B cell differentiation involved in immune response (GO:0002313) | 4.89863224 |
| 21 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.80330204 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.80330204 |
| 23 | neutrophil activation involved in immune response (GO:0002283) | 4.77211075 |
| 24 | translational elongation (GO:0006414) | 4.76617711 |
| 25 | ribosomal small subunit biogenesis (GO:0042274) | 4.75970167 |
| 26 | protein neddylation (GO:0045116) | 4.71808968 |
| 27 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.69063355 |
| 28 | response to interferon-alpha (GO:0035455) | 4.68916484 |
| 29 | cotranslational protein targeting to membrane (GO:0006613) | 4.57780640 |
| 30 | protein targeting to ER (GO:0045047) | 4.54731490 |
| 31 | DNA deamination (GO:0045006) | 4.51687990 |
| 32 | blood coagulation, intrinsic pathway (GO:0007597) | 4.51245606 |
| 33 | maturation of SSU-rRNA (GO:0030490) | 4.50854034 |
| 34 | regulation of integrin activation (GO:0033623) | 4.36110636 |
| 35 | pyrimidine nucleotide catabolic process (GO:0006244) | 4.36105762 |
| 36 | protein localization to endoplasmic reticulum (GO:0070972) | 4.33539029 |
| 37 | regulation of platelet activation (GO:0010543) | 4.32765881 |
| 38 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.32499188 |
| 39 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.32463830 |
| 40 | viral life cycle (GO:0019058) | 4.24516470 |
| 41 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 4.20757036 |
| 42 | heparin metabolic process (GO:0030202) | 4.17889482 |
| 43 | heparin biosynthetic process (GO:0030210) | 4.17889482 |
| 44 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.11616467 |
| 45 | lymph node development (GO:0048535) | 4.06669124 |
| 46 | cellular protein complex disassembly (GO:0043624) | 4.03647656 |
| 47 | secretory granule organization (GO:0033363) | 4.02273828 |
| 48 | platelet aggregation (GO:0070527) | 3.92866246 |
| 49 | positive regulation of B cell differentiation (GO:0045579) | 3.92742661 |
| 50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.90550932 |
| 51 | autophagic vacuole fusion (GO:0000046) | 3.90109190 |
| 52 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.89486998 |
| 53 | lymphoid progenitor cell differentiation (GO:0002320) | 3.87480150 |
| 54 | regulation of platelet aggregation (GO:0090330) | 3.86653010 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.82491641 |
| 56 | translational initiation (GO:0006413) | 3.79282514 |
| 57 | grooming behavior (GO:0007625) | 3.71024638 |
| 58 | protein complex disassembly (GO:0043241) | 3.67916026 |
| 59 | necroptotic process (GO:0070266) | 3.66025187 |
| 60 | mature B cell differentiation (GO:0002335) | 3.64504299 |
| 61 | positive regulation of mast cell activation (GO:0033005) | 3.63190636 |
| 62 | deoxyribonucleotide catabolic process (GO:0009264) | 3.61259712 |
| 63 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.61046964 |
| 64 | negative regulation of stress fiber assembly (GO:0051497) | 3.59674690 |
| 65 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53510659 |
| 66 | L-fucose metabolic process (GO:0042354) | 3.52525179 |
| 67 | L-fucose catabolic process (GO:0042355) | 3.52525179 |
| 68 | fucose catabolic process (GO:0019317) | 3.52525179 |
| 69 | Peyers patch development (GO:0048541) | 3.52084728 |
| 70 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.52084728 |
| 71 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.51837394 |
| 72 | regulation of natural killer cell differentiation (GO:0032823) | 3.46818364 |
| 73 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.45167828 |
| 74 | immunoglobulin mediated immune response (GO:0016064) | 3.45053743 |
| 75 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.45001886 |
| 76 | respiratory chain complex IV assembly (GO:0008535) | 3.44984430 |
| 77 | lipoxygenase pathway (GO:0019372) | 3.44315498 |
| 78 | deoxyribose phosphate catabolic process (GO:0046386) | 3.42609404 |
| 79 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.41777111 |
| 80 | defense response to protozoan (GO:0042832) | 3.41307516 |
| 81 | macromolecular complex disassembly (GO:0032984) | 3.40080813 |
| 82 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.39810656 |
| 83 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.38646258 |
| 84 | positive regulation of T cell cytokine production (GO:0002726) | 3.38114329 |
| 85 | B cell mediated immunity (GO:0019724) | 3.37711708 |
| 86 | T cell homeostasis (GO:0043029) | 3.36092263 |
| 87 | negative regulation of viral entry into host cell (GO:0046597) | 3.33576838 |
| 88 | cyclooxygenase pathway (GO:0019371) | 3.32676341 |
| 89 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.32079463 |
| 90 | embryonic hemopoiesis (GO:0035162) | 3.31802131 |
| 91 | response to protozoan (GO:0001562) | 3.27724279 |
| 92 | purine-containing compound salvage (GO:0043101) | 3.27652957 |
| 93 | mRNA catabolic process (GO:0006402) | 3.26416762 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.26206628 |
| 95 | negative regulation of viral genome replication (GO:0045071) | 3.20908743 |
| 96 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.18772437 |
| 97 | negative regulation of T cell apoptotic process (GO:0070233) | 3.16824794 |
| 98 | positive regulation of granulocyte differentiation (GO:0030854) | 3.14777933 |
| 99 | response to type I interferon (GO:0034340) | 3.11337830 |
| 100 | phospholipid scrambling (GO:0017121) | 3.10634121 |
| 101 | cellular response to type I interferon (GO:0071357) | 3.10615108 |
| 102 | type I interferon signaling pathway (GO:0060337) | 3.10615108 |
| 103 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.07686712 |
| 104 | phagocytosis, engulfment (GO:0006911) | 3.07058369 |
| 105 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.06698257 |
| 106 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.06089924 |
| 107 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.06007392 |
| 108 | mast cell activation (GO:0045576) | 3.05490222 |
| 109 | purinergic receptor signaling pathway (GO:0035587) | 3.04501809 |
| 110 | maternal behavior (GO:0042711) | 3.04302976 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.04201198 |
| 112 | regulation of transmission of nerve impulse (GO:0051969) | 3.04081504 |
| 113 | RNA catabolic process (GO:0006401) | 3.03019927 |
| 114 | ribosomal large subunit biogenesis (GO:0042273) | 3.01469299 |
| 115 | purine nucleotide salvage (GO:0032261) | 3.01353044 |
| 116 | telomere maintenance via recombination (GO:0000722) | 3.00429898 |
| 117 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.99835393 |
| 118 | DNA strand elongation (GO:0022616) | 2.98652445 |
| 119 | regulation of erythrocyte differentiation (GO:0045646) | 2.98599849 |
| 120 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.97774711 |
| 121 | T-helper 1 type immune response (GO:0042088) | 2.96587545 |
| 122 | negative regulation of bone mineralization (GO:0030502) | 2.95706956 |
| 123 | protein targeting to membrane (GO:0006612) | 2.94287631 |
| 124 | monoamine transport (GO:0015844) | 2.94041459 |
| 125 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.93983052 |
| 126 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.93983052 |
| 127 | organelle membrane fusion (GO:0090174) | 2.91817521 |
| 128 | regulation of mast cell activation (GO:0033003) | 2.91128837 |
| 129 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88058745 |
| 130 | regulation of mast cell degranulation (GO:0043304) | 2.87740702 |
| 131 | xenobiotic catabolic process (GO:0042178) | 2.87141962 |
| 132 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87053774 |
| 133 | adenosine receptor signaling pathway (GO:0001973) | 2.85771700 |
| 134 | hyperosmotic salinity response (GO:0042538) | 2.85618145 |
| 135 | neutrophil activation (GO:0042119) | 2.85220134 |
| 136 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.84900987 |
| 137 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.82657637 |
| 138 | IMP metabolic process (GO:0046040) | 2.82033866 |
| 139 | regulation of penile erection (GO:0060405) | 2.81183373 |
| 140 | positive regulation of mast cell degranulation (GO:0043306) | 2.77362381 |
| 141 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.77362381 |
| 142 | programmed necrotic cell death (GO:0097300) | 2.76159213 |
| 143 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.76004178 |
| 144 | plasma membrane fusion (GO:0045026) | 2.75585755 |
| 145 | actin nucleation (GO:0045010) | 2.75557867 |
| 146 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.74448504 |
| 147 | myeloid cell development (GO:0061515) | 2.74446399 |
| 148 | pigment granule organization (GO:0048753) | 2.74023267 |
| 149 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.73793630 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.73728545 |
| 151 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73627095 |
| 152 | negative regulation of norepinephrine secretion (GO:0010700) | 2.72875658 |
| 153 | melanosome organization (GO:0032438) | 2.72725661 |
| 154 | IMP biosynthetic process (GO:0006188) | 2.72295453 |
| 155 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.72283488 |
| 156 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.71550393 |
| 157 | parental behavior (GO:0060746) | 2.71040665 |
| 158 | pseudouridine synthesis (GO:0001522) | 2.71022621 |
| 159 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.70833888 |
| 160 | B cell activation involved in immune response (GO:0002312) | 2.70380674 |
| 161 | positive regulation of vasculogenesis (GO:2001214) | 2.69839287 |
| 162 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.69661471 |
| 163 | regulation of lipoprotein metabolic process (GO:0050746) | 2.68658398 |
| 164 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.68619885 |
| 165 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.68522923 |
| 166 | regulation of B cell differentiation (GO:0045577) | 2.68430832 |
| 167 | L-phenylalanine catabolic process (GO:0006559) | 2.67999496 |
| 168 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.67999496 |
| 169 | deoxyribose phosphate metabolic process (GO:0019692) | 2.67795358 |
| 170 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.67170442 |
| 171 | membrane invagination (GO:0010324) | 2.66959535 |
| 172 | positive regulation of respiratory burst (GO:0060267) | 2.66742182 |
| 173 | regulation of B cell apoptotic process (GO:0002902) | 2.66549420 |
| 174 | cytokine production involved in immune response (GO:0002367) | 2.66301695 |
| 175 | cytochrome complex assembly (GO:0017004) | 2.64160939 |
| 176 | histamine secretion (GO:0001821) | 2.62358666 |
| 177 | seminiferous tubule development (GO:0072520) | 2.62346866 |
| 178 | homotypic cell-cell adhesion (GO:0034109) | 2.61097783 |
| 179 | nucleotide salvage (GO:0043173) | 2.59563061 |
| 180 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.59424143 |
| 181 | negative regulation of response to food (GO:0032096) | 2.58422005 |
| 182 | negative regulation of appetite (GO:0032099) | 2.58422005 |
| 183 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.57639253 |
| 184 | cellular response to exogenous dsRNA (GO:0071360) | 2.57283200 |
| 185 | regulation of RIG-I signaling pathway (GO:0039535) | 2.54849210 |
| 186 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.54798532 |
| 187 | positive regulation of hemostasis (GO:1900048) | 2.53299042 |
| 188 | positive regulation of blood coagulation (GO:0030194) | 2.53299042 |
| 189 | negative regulation of heart rate (GO:0010459) | 2.52441943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.54258599 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.04634767 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.88282072 |
| 4 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.87418284 |
| 5 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.57812777 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.35620216 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.33029004 |
| 8 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.21249467 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.20545355 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.13358746 |
| 11 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.06723427 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.97639653 |
| 13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.93806190 |
| 14 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.88456497 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.86368756 |
| 16 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76088829 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73987099 |
| 18 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.71829041 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.59758710 |
| 20 | GATA1_19941826_ChIP-Seq_K562_Human | 2.46332867 |
| 21 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.36285295 |
| 22 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.28998036 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25996590 |
| 24 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.23015227 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.20970856 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20313939 |
| 27 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18574353 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.15892676 |
| 29 | MYC_22102868_ChIP-Seq_BL_Human | 2.14034201 |
| 30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.13962112 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12421641 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09319456 |
| 33 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03895786 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.99099955 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98744330 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93159843 |
| 37 | GATA2_19941826_ChIP-Seq_K562_Human | 1.92939083 |
| 38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.87542186 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86398140 |
| 40 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86229356 |
| 41 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.85845325 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84973300 |
| 43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.84266952 |
| 44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.82952487 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.82394335 |
| 46 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.79006555 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.78326481 |
| 48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77390539 |
| 49 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.76381324 |
| 50 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.75699948 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.75017823 |
| 52 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.72893285 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68925751 |
| 54 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.68218809 |
| 55 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.64690840 |
| 56 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63719744 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.63093646 |
| 58 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.62408349 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.58358510 |
| 60 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56478374 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55520452 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52466944 |
| 63 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.52045202 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51094286 |
| 65 | MYB_26560356_Chip-Seq_TH1_Human | 1.49014055 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.48974690 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46898437 |
| 68 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46803789 |
| 69 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43195880 |
| 70 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39430005 |
| 71 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.39373439 |
| 72 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39225677 |
| 73 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38839865 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38508306 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36673233 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.34991613 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33597771 |
| 78 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33186867 |
| 79 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30470653 |
| 80 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.29840328 |
| 81 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.29493353 |
| 82 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27734236 |
| 83 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27143042 |
| 84 | P300_27268052_Chip-Seq_Bcells_Human | 1.26316125 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.25654133 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.24940034 |
| 87 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23983745 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23967847 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.23518662 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22151174 |
| 91 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.22089680 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.20029528 |
| 93 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.19745403 |
| 94 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.19129783 |
| 95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17651999 |
| 96 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.16662971 |
| 97 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.16273366 |
| 98 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15959477 |
| 99 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15944795 |
| 100 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.13962890 |
| 101 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13695067 |
| 102 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13647598 |
| 103 | AR_20517297_ChIP-Seq_VCAP_Human | 1.13203787 |
| 104 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12448618 |
| 105 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.11430131 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10195680 |
| 107 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.08594702 |
| 108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08515836 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08153054 |
| 110 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08072495 |
| 111 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07244112 |
| 112 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.06472527 |
| 113 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06272827 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04537850 |
| 115 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.03987392 |
| 116 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.03300344 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02371999 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01628432 |
| 119 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.01443519 |
| 120 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01222283 |
| 121 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00906912 |
| 122 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.99719415 |
| 123 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.99501521 |
| 124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98791450 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98588623 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97081050 |
| 127 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.97061701 |
| 128 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.95525886 |
| 129 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95135759 |
| 130 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93715088 |
| 131 | EWS_26573619_Chip-Seq_HEK293_Human | 0.92752592 |
| 132 | MAF_26560356_Chip-Seq_TH2_Human | 0.92449957 |
| 133 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91989238 |
| 134 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91950816 |
| 135 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.91805788 |
| 136 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.91582602 |
| 137 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.91500381 |
| 138 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91104428 |
| 139 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.91076814 |
| 140 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90909102 |
| 141 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90908736 |
| 142 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89728849 |
| 143 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.89532060 |
| 144 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.89388736 |
| 145 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88058374 |
| 146 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87289763 |
| 147 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.86394174 |
| 148 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.86180284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 4.28966560 |
| 2 | MP0008004_abnormal_stomach_pH | 3.89938521 |
| 3 | MP0005174_abnormal_tail_pigmentation | 3.34030401 |
| 4 | MP0004147_increased_porphyrin_level | 3.26241231 |
| 5 | MP0005397_hematopoietic_system_phenotyp | 3.21577163 |
| 6 | MP0001545_abnormal_hematopoietic_system | 3.21577163 |
| 7 | * MP0004808_abnormal_hematopoietic_stem | 3.20062808 |
| 8 | MP0005464_abnormal_platelet_physiology | 3.18110284 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.13859563 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 3.04468335 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 2.87030685 |
| 12 | MP0005646_abnormal_pituitary_gland | 2.81342850 |
| 13 | MP0000685_abnormal_immune_system | 2.78680537 |
| 14 | MP0009785_altered_susceptibility_to | 2.77720227 |
| 15 | MP0005671_abnormal_response_to | 2.66330912 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.47232424 |
| 17 | MP0002095_abnormal_skin_pigmentation | 2.40562734 |
| 18 | MP0009379_abnormal_foot_pigmentation | 2.35740978 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.24406016 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.18601415 |
| 21 | * MP0002398_abnormal_bone_marrow | 2.17016476 |
| 22 | MP0005025_abnormal_response_to | 2.16288843 |
| 23 | MP0006054_spinal_hemorrhage | 2.15438963 |
| 24 | MP0000490_abnormal_crypts_of | 1.98309630 |
| 25 | MP0002736_abnormal_nociception_after | 1.95916342 |
| 26 | * MP0000689_abnormal_spleen_morphology | 1.92742075 |
| 27 | MP0001800_abnormal_humoral_immune | 1.92247436 |
| 28 | MP0003866_abnormal_defecation | 1.87451865 |
| 29 | MP0005410_abnormal_fertilization | 1.85778239 |
| 30 | MP0009278_abnormal_bone_marrow | 1.83922073 |
| 31 | MP0003718_maternal_effect | 1.83592652 |
| 32 | MP0003943_abnormal_hepatobiliary_system | 1.83406287 |
| 33 | MP0002420_abnormal_adaptive_immunity | 1.82151054 |
| 34 | MP0002452_abnormal_antigen_presenting | 1.81730596 |
| 35 | * MP0002722_abnormal_immune_system | 1.80201388 |
| 36 | MP0001819_abnormal_immune_cell | 1.78607414 |
| 37 | * MP0002723_abnormal_immune_serum | 1.77500302 |
| 38 | MP0003724_increased_susceptibility_to | 1.77429206 |
| 39 | MP0000230_abnormal_systemic_arterial | 1.75811938 |
| 40 | MP0008775_abnormal_heart_ventricle | 1.75381003 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.72231310 |
| 42 | MP0001853_heart_inflammation | 1.71452836 |
| 43 | MP0003787_abnormal_imprinting | 1.70826863 |
| 44 | * MP0000716_abnormal_immune_system | 1.70470804 |
| 45 | MP0002148_abnormal_hypersensitivity_rea | 1.68047651 |
| 46 | * MP0002429_abnormal_blood_cell | 1.65546620 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.65273378 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.64632776 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.64290914 |
| 50 | MP0003303_peritoneal_inflammation | 1.59849351 |
| 51 | MP0006292_abnormal_olfactory_placode | 1.58146303 |
| 52 | MP0001968_abnormal_touch/_nociception | 1.57844618 |
| 53 | MP0001873_stomach_inflammation | 1.55466084 |
| 54 | MP0001188_hyperpigmentation | 1.55018924 |
| 55 | MP0008007_abnormal_cellular_replicative | 1.54142597 |
| 56 | MP0000015_abnormal_ear_pigmentation | 1.53278329 |
| 57 | MP0003436_decreased_susceptibility_to | 1.50295946 |
| 58 | MP0008872_abnormal_physiological_respon | 1.48263457 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.46968014 |
| 60 | MP0005165_increased_susceptibility_to | 1.46848229 |
| 61 | MP0000383_abnormal_hair_follicle | 1.46842471 |
| 62 | MP0010094_abnormal_chromosome_stability | 1.43809886 |
| 63 | MP0009697_abnormal_copulation | 1.42378936 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.41627673 |
| 65 | MP0005409_darkened_coat_color | 1.39398399 |
| 66 | MP0002419_abnormal_innate_immunity | 1.38986778 |
| 67 | MP0005083_abnormal_biliary_tract | 1.35579492 |
| 68 | MP0004084_abnormal_cardiac_muscle | 1.33755118 |
| 69 | MP0001790_abnormal_immune_system | 1.31599122 |
| 70 | MP0005387_immune_system_phenotype | 1.31599122 |
| 71 | MP0008058_abnormal_DNA_repair | 1.30468308 |
| 72 | MP0002733_abnormal_thermal_nociception | 1.29669648 |
| 73 | MP0003868_abnormal_feces_composition | 1.25000983 |
| 74 | MP0003011_delayed_dark_adaptation | 1.23688689 |
| 75 | MP0002006_tumorigenesis | 1.18666184 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.15983306 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.15874010 |
| 78 | MP0006276_abnormal_autonomic_nervous | 1.14315461 |
| 79 | MP0008057_abnormal_DNA_replication | 1.13925485 |
| 80 | MP0000681_abnormal_thyroid_gland | 1.12142768 |
| 81 | MP0003075_altered_response_to | 1.12031694 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.09723680 |
| 83 | MP0001851_eye_inflammation | 1.09723419 |
| 84 | MP0009333_abnormal_splenocyte_physiolog | 1.09484628 |
| 85 | MP0004510_myositis | 1.07012271 |
| 86 | MP0001533_abnormal_skeleton_physiology | 1.03665974 |
| 87 | MP0002009_preneoplasia | 1.03515299 |
| 88 | MP0004484_altered_response_of | 1.02905746 |
| 89 | MP0002075_abnormal_coat/hair_pigmentati | 1.02508549 |
| 90 | MP0001348_abnormal_lacrimal_gland | 1.01332540 |
| 91 | MP0006036_abnormal_mitochondrial_physio | 1.01098874 |
| 92 | MP0002405_respiratory_system_inflammati | 1.00677058 |
| 93 | MP0003172_abnormal_lysosome_physiology | 0.99171244 |
| 94 | MP0000313_abnormal_cell_death | 0.98709329 |
| 95 | MP0001664_abnormal_digestion | 0.98305166 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.97748462 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.97589350 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.96944746 |
| 99 | MP0002132_abnormal_respiratory_system | 0.95321639 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.95142454 |
| 101 | MP0001663_abnormal_digestive_system | 0.94887542 |
| 102 | MP0002735_abnormal_chemical_nociception | 0.94442490 |
| 103 | * MP0008469_abnormal_protein_level | 0.92724644 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.90529759 |
| 105 | MP0001879_abnormal_lymphatic_vessel | 0.90353740 |
| 106 | MP0002938_white_spotting | 0.90104632 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.89665968 |
| 108 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89473114 |
| 109 | MP0003077_abnormal_cell_cycle | 0.87080918 |
| 110 | * MP0009642_abnormal_blood_homeostasis | 0.86146259 |
| 111 | MP0003828_pulmonary_edema | 0.85902350 |
| 112 | MP0005670_abnormal_white_adipose | 0.84865395 |
| 113 | MP0002877_abnormal_melanocyte_morpholog | 0.84194083 |
| 114 | MP0005535_abnormal_body_temperature | 0.83009925 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.82764988 |
| 116 | MP0010386_abnormal_urinary_bladder | 0.81991821 |
| 117 | MP0004036_abnormal_muscle_relaxation | 0.81482850 |
| 118 | MP0003786_premature_aging | 0.80280799 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.80157216 |
| 120 | MP0003693_abnormal_embryo_hatching | 0.80114375 |
| 121 | MP0004957_abnormal_blastocyst_morpholog | 0.79831758 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.78350505 |
| 123 | MP0001764_abnormal_homeostasis | 0.76583105 |
| 124 | MP0005058_abnormal_lysosome_morphology | 0.76254136 |
| 125 | MP0004130_abnormal_muscle_cell | 0.76066467 |
| 126 | MP0004947_skin_inflammation | 0.75935126 |
| 127 | MP0000249_abnormal_blood_vessel | 0.75143264 |
| 128 | MP0001970_abnormal_pain_threshold | 0.74147058 |
| 129 | MP0000372_irregular_coat_pigmentation | 0.72824215 |
| 130 | MP0009764_decreased_sensitivity_to | 0.71370309 |
| 131 | MP0003252_abnormal_bile_duct | 0.71091473 |
| 132 | MP0003186_abnormal_redox_activity | 0.70772124 |
| 133 | MP0005636_abnormal_mineral_homeostasis | 0.70196585 |
| 134 | MP0000477_abnormal_intestine_morphology | 0.69096712 |
| 135 | MP0001905_abnormal_dopamine_level | 0.68640534 |
| 136 | MP0000598_abnormal_liver_morphology | 0.68268355 |
| 137 | MP0010329_abnormal_lipoprotein_level | 0.67451590 |
| 138 | MP0006082_CNS_inflammation | 0.67283238 |
| 139 | MP0005084_abnormal_gallbladder_morpholo | 0.67129187 |
| 140 | MP0003300_gastrointestinal_ulcer | 0.66749439 |
| 141 | MP0008874_decreased_physiological_sensi | 0.66717200 |
| 142 | MP0003638_abnormal_response/metabolism_ | 0.63502525 |
| 143 | MP0003315_abnormal_perineum_morphology | 0.63158441 |
| 144 | MP0002933_joint_inflammation | 0.62451924 |
| 145 | MP0008995_early_reproductive_senescence | 0.62178377 |
| 146 | MP0009763_increased_sensitivity_to | 0.60433813 |
| 147 | MP0000343_altered_response_to | 0.57859064 |
| 148 | MP0005310_abnormal_salivary_gland | 0.51809346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 7.29941125 |
| 2 | Aplastic anemia (HP:0001915) | 6.24505907 |
| 3 | Prolonged bleeding time (HP:0003010) | 5.64200153 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.81817299 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.72244385 |
| 6 | * Gingival bleeding (HP:0000225) | 4.40620773 |
| 7 | Myositis (HP:0100614) | 4.25689914 |
| 8 | Petechiae (HP:0000967) | 4.21038221 |
| 9 | IgM deficiency (HP:0002850) | 4.09744724 |
| 10 | Type 2 muscle fiber atrophy (HP:0003554) | 3.99727481 |
| 11 | Muscle fiber atrophy (HP:0100295) | 3.94621490 |
| 12 | Chronic otitis media (HP:0000389) | 3.86782282 |
| 13 | Dyschromatopsia (HP:0007641) | 3.84079091 |
| 14 | Reticulocytopenia (HP:0001896) | 3.73319774 |
| 15 | * Epistaxis (HP:0000421) | 3.63770831 |
| 16 | Type I transferrin isoform profile (HP:0003642) | 3.41007215 |
| 17 | Abnormal platelet function (HP:0011869) | 3.39069792 |
| 18 | Impaired platelet aggregation (HP:0003540) | 3.39069792 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 3.38499854 |
| 20 | Acute myeloid leukemia (HP:0004808) | 3.38440130 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.34421578 |
| 22 | Pallor (HP:0000980) | 3.33748842 |
| 23 | * Thrombocytosis (HP:0001894) | 3.25803729 |
| 24 | Poikilocytosis (HP:0004447) | 3.20910303 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.20889344 |
| 26 | Purpura (HP:0000979) | 3.19423376 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 2.99424847 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 2.98908614 |
| 29 | Fatigue (HP:0012378) | 2.97163482 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.92088288 |
| 31 | Decreased central vision (HP:0007663) | 2.90392334 |
| 32 | Gonadotropin excess (HP:0000837) | 2.87082064 |
| 33 | Hyperthyroidism (HP:0000836) | 2.84545825 |
| 34 | Spontaneous hematomas (HP:0007420) | 2.80161995 |
| 35 | Hyperglycinemia (HP:0002154) | 2.79323115 |
| 36 | Asplenia (HP:0001746) | 2.78312921 |
| 37 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.76581096 |
| 38 | Recurrent bronchitis (HP:0002837) | 2.75907321 |
| 39 | Paralysis (HP:0003470) | 2.75387644 |
| 40 | Hypothermia (HP:0002045) | 2.73883476 |
| 41 | Abnormality of the nasal mucosa (HP:0000433) | 2.72332134 |
| 42 | Syringomyelia (HP:0003396) | 2.69451282 |
| 43 | Spinal cord lesions (HP:0100561) | 2.69451282 |
| 44 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.68350953 |
| 45 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.68350953 |
| 46 | Abnormal protein glycosylation (HP:0012346) | 2.68350953 |
| 47 | Abnormal glycosylation (HP:0012345) | 2.68350953 |
| 48 | Stomatitis (HP:0010280) | 2.67876558 |
| 49 | Acanthocytosis (HP:0001927) | 2.66538379 |
| 50 | Nonprogressive disorder (HP:0003680) | 2.66347368 |
| 51 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.65841737 |
| 52 | Macrocytic anemia (HP:0001972) | 2.64170170 |
| 53 | Microcytic anemia (HP:0001935) | 2.60744805 |
| 54 | Abnormality of iron homeostasis (HP:0011031) | 2.60611117 |
| 55 | Abnormality of T cell physiology (HP:0011840) | 2.54341557 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.53952630 |
| 57 | Abnormal pupillary function (HP:0007686) | 2.53562649 |
| 58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.52800127 |
| 59 | Lip pit (HP:0100267) | 2.50218559 |
| 60 | Albinism (HP:0001022) | 2.49702629 |
| 61 | Acute lymphatic leukemia (HP:0006721) | 2.48609453 |
| 62 | * Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.47508273 |
| 63 | Erythema (HP:0010783) | 2.46037342 |
| 64 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.44521297 |
| 65 | Abolished electroretinogram (ERG) (HP:0000550) | 2.43666833 |
| 66 | Beaking of vertebral bodies (HP:0004568) | 2.38288369 |
| 67 | Menorrhagia (HP:0000132) | 2.36997820 |
| 68 | IgG deficiency (HP:0004315) | 2.36346666 |
| 69 | Obstructive lung disease (HP:0006536) | 2.35554222 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.35554222 |
| 71 | Colon cancer (HP:0003003) | 2.34054746 |
| 72 | Recurrent viral infections (HP:0004429) | 2.33825802 |
| 73 | Depressed nasal tip (HP:0000437) | 2.33393858 |
| 74 | 11 pairs of ribs (HP:0000878) | 2.33250320 |
| 75 | Abnormality of the columella (HP:0009929) | 2.32499355 |
| 76 | Hepatosplenomegaly (HP:0001433) | 2.32333420 |
| 77 | Patchy hypopigmentation of hair (HP:0011365) | 2.31128434 |
| 78 | Abnormality of the prostate (HP:0008775) | 2.28329040 |
| 79 | Agammaglobulinemia (HP:0004432) | 2.27231450 |
| 80 | * Myelodysplasia (HP:0002863) | 2.26722141 |
| 81 | Hypoproteinemia (HP:0003075) | 2.24619130 |
| 82 | Generalized aminoaciduria (HP:0002909) | 2.22103856 |
| 83 | Hyperglycinuria (HP:0003108) | 2.22029326 |
| 84 | Cellulitis (HP:0100658) | 2.21955310 |
| 85 | Orchitis (HP:0100796) | 2.19760812 |
| 86 | Weak cry (HP:0001612) | 2.17959320 |
| 87 | Increased cerebral lipofuscin (HP:0011813) | 2.17346705 |
| 88 | Lymphoma (HP:0002665) | 2.16241042 |
| 89 | Abnormality of B cell number (HP:0010975) | 2.14778305 |
| 90 | B lymphocytopenia (HP:0010976) | 2.14778305 |
| 91 | Central scotoma (HP:0000603) | 2.14578345 |
| 92 | Renal cortical cysts (HP:0000803) | 2.13863648 |
| 93 | Neutropenia (HP:0001875) | 2.12016020 |
| 94 | Microretrognathia (HP:0000308) | 2.11702431 |
| 95 | Increased IgM level (HP:0003496) | 2.11344581 |
| 96 | Stomach cancer (HP:0012126) | 2.10464664 |
| 97 | Acute hepatic failure (HP:0006554) | 2.08828515 |
| 98 | Abnormal platelet volume (HP:0011876) | 2.08524165 |
| 99 | Increased muscle lipid content (HP:0009058) | 2.05566403 |
| 100 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05325328 |
| 101 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05325328 |
| 102 | Exertional dyspnea (HP:0002875) | 2.04491983 |
| 103 | * Pancytopenia (HP:0001876) | 2.02359235 |
| 104 | Encephalitis (HP:0002383) | 2.02142992 |
| 105 | Abnormality of T cells (HP:0002843) | 2.02024752 |
| 106 | Abnormality of male internal genitalia (HP:0000022) | 2.01309935 |
| 107 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.01107654 |
| 108 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.00663574 |
| 109 | Poikiloderma (HP:0001029) | 1.98209433 |
| 110 | Gastrointestinal inflammation (HP:0004386) | 1.97184056 |
| 111 | Increased serum ferritin (HP:0003281) | 1.96775813 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95887488 |
| 113 | Granulocytopenia (HP:0001913) | 1.95147811 |
| 114 | Posterior subcapsular cataract (HP:0007787) | 1.94829633 |
| 115 | Recurrent bacterial skin infections (HP:0005406) | 1.94592304 |
| 116 | Abnormal auditory evoked potentials (HP:0006958) | 1.94534911 |
| 117 | Recurrent abscess formation (HP:0002722) | 1.94516044 |
| 118 | Hepatocellular necrosis (HP:0001404) | 1.94191142 |
| 119 | Nasal polyposis (HP:0100582) | 1.94133455 |
| 120 | Neonatal hypoglycemia (HP:0001998) | 1.93316472 |
| 121 | Thyroid-stimulating hormone excess (HP:0002925) | 1.92612763 |
| 122 | Gastrointestinal stroma tumor (HP:0100723) | 1.92053255 |
| 123 | Microvesicular hepatic steatosis (HP:0001414) | 1.91977801 |
| 124 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91259310 |
| 125 | Easy fatigability (HP:0003388) | 1.90213244 |
| 126 | Hypoplasia of the thymus (HP:0000778) | 1.89833073 |
| 127 | Lymphopenia (HP:0001888) | 1.89816786 |
| 128 | White forelock (HP:0002211) | 1.89449504 |
| 129 | Abnormality of the renal cortex (HP:0011035) | 1.89154606 |
| 130 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.88295254 |
| 131 | Birth length less than 3rd percentile (HP:0003561) | 1.88114682 |
| 132 | 3-Methylglutaconic aciduria (HP:0003535) | 1.87597216 |
| 133 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.86803251 |
| 134 | Dicarboxylic aciduria (HP:0003215) | 1.86803251 |
| 135 | Cerebral palsy (HP:0100021) | 1.85587751 |
| 136 | Optic neuritis (HP:0100653) | 1.85316104 |
| 137 | Retrobulbar optic neuritis (HP:0100654) | 1.85316104 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.84296042 |
| 139 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.84296042 |
| 140 | Ileus (HP:0002595) | 1.82884520 |
| 141 | Increased intramyocellular lipid droplets (HP:0012240) | 1.82539404 |
| 142 | Facial diplegia (HP:0001349) | 1.81680910 |
| 143 | Hyperpituitarism (HP:0010514) | 1.81013410 |
| 144 | Inflammation of the large intestine (HP:0002037) | 1.80392044 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.78832334 |
| 146 | Meningitis (HP:0001287) | 1.78227107 |
| 147 | Recurrent skin infections (HP:0001581) | 1.78223876 |
| 148 | * Bruising susceptibility (HP:0000978) | 1.77992606 |
| 149 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.77868314 |
| 150 | Bone marrow hypocellularity (HP:0005528) | 1.77372253 |
| 151 | Visual hallucinations (HP:0002367) | 1.76310289 |
| 152 | Episodic fever (HP:0001954) | 1.76165268 |
| 153 | Attenuation of retinal blood vessels (HP:0007843) | 1.75271027 |
| 154 | Hypertensive crisis (HP:0100735) | 1.74980108 |
| 155 | Hepatic necrosis (HP:0002605) | 1.73467901 |
| 156 | Joint swelling (HP:0001386) | 1.72246639 |
| 157 | Abnormality of renal resorption (HP:0011038) | 1.66069355 |
| 158 | Enlarged kidneys (HP:0000105) | 1.65023422 |
| 159 | Eosinophilia (HP:0001880) | 1.64775118 |
| 160 | Seborrheic dermatitis (HP:0001051) | 1.64552312 |
| 161 | Congenital stationary night blindness (HP:0007642) | 1.60053966 |
| 162 | Nausea (HP:0002018) | 1.59311573 |
| 163 | Abnormality of lateral ventricle (HP:0030047) | 1.56902677 |
| 164 | Leukocytosis (HP:0001974) | 1.56579765 |
| 165 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.56080706 |
| 166 | Joint hemorrhage (HP:0005261) | 1.56077350 |
| 167 | Autoimmune thrombocytopenia (HP:0001973) | 1.55380505 |
| 168 | Mitochondrial inheritance (HP:0001427) | 1.55311955 |
| 169 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.55207764 |
| 170 | Brushfield spots (HP:0001088) | 1.54555456 |
| 171 | Abnormal drinking behavior (HP:0030082) | 1.54434063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR1 | 3.39169671 |
| 2 | TIE1 | 3.34305295 |
| 3 | KIT | 3.16681186 |
| 4 | NME2 | 3.12925300 |
| 5 | STK16 | 3.09661645 |
| 6 | TNIK | 3.00315786 |
| 7 | WEE1 | 2.81833484 |
| 8 | MST4 | 2.77006879 |
| 9 | MUSK | 2.73038241 |
| 10 | MAP4K1 | 2.63811682 |
| 11 | MAP2K3 | 2.62399145 |
| 12 | CDK19 | 2.51129925 |
| 13 | RIPK4 | 2.44655634 |
| 14 | ZAK | 2.39734479 |
| 15 | BTK | 2.30464326 |
| 16 | FLT3 | 2.29986147 |
| 17 | JAK3 | 2.28156812 |
| 18 | TGFBR2 | 2.27085280 |
| 19 | NUAK1 | 2.24818389 |
| 20 | EEF2K | 2.09637744 |
| 21 | TEC | 2.07188222 |
| 22 | MATK | 1.99059457 |
| 23 | BRSK2 | 1.95443554 |
| 24 | ACVR1B | 1.92936116 |
| 25 | BMX | 1.90765871 |
| 26 | ITK | 1.88526930 |
| 27 | MKNK1 | 1.83185004 |
| 28 | TLK1 | 1.82715438 |
| 29 | MAPKAPK5 | 1.77942886 |
| 30 | CSF1R | 1.77935528 |
| 31 | RPS6KB2 | 1.74982705 |
| 32 | SCYL2 | 1.61341467 |
| 33 | BCKDK | 1.59822386 |
| 34 | TXK | 1.58119338 |
| 35 | MAP3K12 | 1.55959000 |
| 36 | GRK6 | 1.49584622 |
| 37 | ZAP70 | 1.47970854 |
| 38 | PTK2B | 1.41320294 |
| 39 | VRK1 | 1.40371530 |
| 40 | MAP2K6 | 1.37725716 |
| 41 | MAP4K2 | 1.31364991 |
| 42 | SYK | 1.30746657 |
| 43 | CAMKK2 | 1.29983252 |
| 44 | DAPK2 | 1.29971612 |
| 45 | PIM2 | 1.28409464 |
| 46 | PASK | 1.25332435 |
| 47 | CDK8 | 1.24959425 |
| 48 | EIF2AK1 | 1.24331832 |
| 49 | CCNB1 | 1.19904485 |
| 50 | TBK1 | 1.17991410 |
| 51 | IKBKE | 1.17375932 |
| 52 | ADRBK2 | 1.16170621 |
| 53 | GRK5 | 1.16063839 |
| 54 | IKBKB | 1.10827390 |
| 55 | TNK2 | 1.08094729 |
| 56 | TESK2 | 0.97448894 |
| 57 | PRKCQ | 0.96772960 |
| 58 | NLK | 0.95609876 |
| 59 | FES | 0.93791760 |
| 60 | CAMK1 | 0.91964218 |
| 61 | MAPKAPK3 | 0.91144793 |
| 62 | BMPR2 | 0.90634311 |
| 63 | LCK | 0.89380532 |
| 64 | PRKG2 | 0.88356265 |
| 65 | MAP3K13 | 0.83919200 |
| 66 | MAP3K6 | 0.83261619 |
| 67 | PIK3CG | 0.82815544 |
| 68 | LYN | 0.81383158 |
| 69 | STK4 | 0.80624010 |
| 70 | MAP3K7 | 0.79719671 |
| 71 | MAP3K14 | 0.79255805 |
| 72 | MKNK2 | 0.79131750 |
| 73 | ADRBK1 | 0.79065918 |
| 74 | BLK | 0.79044705 |
| 75 | MYLK | 0.76749836 |
| 76 | DYRK3 | 0.74752288 |
| 77 | IRAK4 | 0.71908994 |
| 78 | MAP2K7 | 0.71580999 |
| 79 | MAP3K5 | 0.71521967 |
| 80 | VRK2 | 0.70106448 |
| 81 | GRK1 | 0.68974988 |
| 82 | PKN2 | 0.68356348 |
| 83 | HIPK2 | 0.68097930 |
| 84 | KDR | 0.66956542 |
| 85 | DAPK3 | 0.66694963 |
| 86 | FRK | 0.65682963 |
| 87 | TYK2 | 0.65139219 |
| 88 | DAPK1 | 0.64340623 |
| 89 | PLK2 | 0.61451526 |
| 90 | FER | 0.61040412 |
| 91 | BRSK1 | 0.60765564 |
| 92 | RAF1 | 0.58935268 |
| 93 | LRRK2 | 0.58220009 |
| 94 | ATR | 0.57654855 |
| 95 | CDC7 | 0.56674339 |
| 96 | PAK1 | 0.54567042 |
| 97 | CDK7 | 0.54218544 |
| 98 | PIM1 | 0.54096248 |
| 99 | CDK9 | 0.53451925 |
| 100 | JAK2 | 0.52663595 |
| 101 | IRAK1 | 0.51933634 |
| 102 | MAP3K1 | 0.51898537 |
| 103 | MAPK4 | 0.51333610 |
| 104 | RIPK1 | 0.50707195 |
| 105 | MAPK11 | 0.50538948 |
| 106 | HCK | 0.50402092 |
| 107 | PRKCD | 0.49638823 |
| 108 | PBK | 0.49098987 |
| 109 | IGF1R | 0.48393267 |
| 110 | BMPR1B | 0.47438926 |
| 111 | PDK1 | 0.45360606 |
| 112 | CHUK | 0.45167892 |
| 113 | TRPM7 | 0.45097207 |
| 114 | PKN1 | 0.43082006 |
| 115 | CLK1 | 0.42983734 |
| 116 | STK3 | 0.42766038 |
| 117 | PHKG2 | 0.42717486 |
| 118 | PHKG1 | 0.42717486 |
| 119 | ABL1 | 0.42412199 |
| 120 | PRKCA | 0.42150976 |
| 121 | RPS6KA6 | 0.41097074 |
| 122 | RPS6KA5 | 0.40413425 |
| 123 | PRKD1 | 0.39911486 |
| 124 | SIK3 | 0.39623255 |
| 125 | TAOK3 | 0.38736165 |
| 126 | FGR | 0.38666586 |
| 127 | PINK1 | 0.37861903 |
| 128 | ARAF | 0.36170604 |
| 129 | PIK3CA | 0.35873926 |
| 130 | MAP3K11 | 0.35804191 |
| 131 | MAP3K3 | 0.34539138 |
| 132 | TAOK2 | 0.34538153 |
| 133 | ABL2 | 0.34445275 |
| 134 | WNK4 | 0.34154173 |
| 135 | MAPK3 | 0.33936010 |
| 136 | CSNK1G3 | 0.33905205 |
| 137 | MAPK13 | 0.30052644 |
| 138 | INSRR | 0.29963626 |
| 139 | PAK4 | 0.29134674 |
| 140 | PRKACG | 0.28824921 |
| 141 | MOS | 0.28519493 |
| 142 | ERN1 | 0.27886346 |
| 143 | CDK4 | 0.25773479 |
| 144 | IRAK3 | 0.24762985 |
| 145 | SRPK1 | 0.24705922 |
| 146 | RPS6KC1 | 0.24196012 |
| 147 | RPS6KL1 | 0.24196012 |
| 148 | SRC | 0.23756272 |
| 149 | GRK7 | 0.23183662 |
| 150 | MAPK15 | 0.22471009 |
| 151 | CSNK2A2 | 0.22439910 |
| 152 | NEK2 | 0.22082963 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.36940054 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.46719419 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.64595966 |
| 4 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.79176143 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.71779609 |
| 6 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.71205748 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.65474191 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.58061666 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.37527507 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.33579365 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.33527283 |
| 12 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.30058613 |
| 13 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.26424097 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.19530907 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 2.08416118 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.95071010 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.88392336 |
| 18 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.77893328 |
| 19 | Platelet activation_Homo sapiens_hsa04611 | 1.75503272 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.74799717 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72855421 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69347163 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.66906349 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.64953528 |
| 25 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.62749828 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62062752 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.58634801 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.55887494 |
| 29 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51225023 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51064253 |
| 31 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43645080 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.38756369 |
| 33 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.38159181 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.37671209 |
| 35 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.37312333 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.32959017 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.28101315 |
| 38 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24831972 |
| 39 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.24554503 |
| 40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.23451378 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.19670018 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.19091433 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14655485 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14584606 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14055207 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13045010 |
| 47 | Basal transcription factors_Homo sapiens_hsa03022 | 1.12263654 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11121881 |
| 49 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09022925 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 1.08958075 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 1.08153846 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07890680 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.04693902 |
| 54 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03856926 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02226906 |
| 56 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01833024 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.01528493 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98072087 |
| 59 | Peroxisome_Homo sapiens_hsa04146 | 0.97697308 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97632070 |
| 61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97514231 |
| 62 | Alcoholism_Homo sapiens_hsa05034 | 0.95215741 |
| 63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94671627 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94370838 |
| 65 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93739905 |
| 66 | RNA transport_Homo sapiens_hsa03013 | 0.91962215 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90477561 |
| 68 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.88674534 |
| 69 | Influenza A_Homo sapiens_hsa05164 | 0.88250898 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85225570 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84886114 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84436712 |
| 73 | Protein export_Homo sapiens_hsa03060 | 0.84258974 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.81799356 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79840969 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.79275575 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78076463 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77921499 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77381502 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76834328 |
| 81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.76176955 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | 0.75965849 |
| 83 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75065217 |
| 84 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72648692 |
| 85 | Proteasome_Homo sapiens_hsa03050 | 0.71765830 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71549924 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.70936771 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.70818120 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69781751 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69368339 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69282800 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.69205134 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67413528 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67387011 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65225307 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.64349921 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63751216 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63240799 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61333610 |
| 100 | Malaria_Homo sapiens_hsa05144 | 0.59784442 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59429189 |
| 102 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59006234 |
| 103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58613568 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.57762774 |
| 105 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56531340 |
| 106 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55542832 |
| 107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54316664 |
| 108 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.54017971 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53905307 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53071377 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52818114 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50231625 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.49656719 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.46211997 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45692463 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.45299151 |
| 117 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45184803 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44605029 |
| 119 | Asthma_Homo sapiens_hsa05310 | 0.44138433 |
| 120 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43172605 |
| 121 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42212117 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41355098 |
| 123 | Salmonella infection_Homo sapiens_hsa05132 | 0.40015680 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.39738907 |
| 125 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38952893 |
| 126 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38446029 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37120529 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.36247654 |
| 129 | Long-term depression_Homo sapiens_hsa04730 | 0.36047855 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35018379 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.34332071 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34000269 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33345024 |
| 134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31514803 |
| 135 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31341946 |
| 136 | Tuberculosis_Homo sapiens_hsa05152 | 0.30912126 |
| 137 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29114310 |
| 138 | Retinol metabolism_Homo sapiens_hsa00830 | 0.29053878 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28831814 |
| 140 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28008751 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.26976184 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26846713 |
| 143 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.26372194 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25231625 |
| 145 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.24931402 |
| 146 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.22469270 |
| 147 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22442054 |
| 148 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22112621 |
| 149 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.20640644 |
| 150 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.20385422 |
| 151 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.19183296 |

